In a July 2026 episode of Exchanges: A Cambridge UP Podcast, David Teece, in conversation with Alfred Marcus, discusses why higher education leaders must adapt new approaches in an uncertain era.
Read MoreCommentary in Health Care Analysis
A July 2026 commentary from Eira Research Fellow Kristina Acri challenges a recent analysis claiming that patents contribute to premature deaths among people with diabetes.
Read MoreDynamic Competition Featured in Bloomberg Television Segment
An August 1, 2026 feature from Bloomberg Television, “Will New Merger Rules Save the EU in the AI Race?” covered the dynamic competition framework as part of new European Union guidelines for merger analysis.
Read MoreHow patenting reliability influences R&D financing
In a new working paper, “Declining Patent Reliability and Venture Capital Reallocation,” Mark Schultz finds investment shifted away from patent-intensive sectors in the United States between 2004 to 2017.
Read MoreThe need for regional research strategies at US universities
in Leadership, Strategy
In a July 2026 comment letter published by Issues in Science and Technology, Eion Lys discusses why American research universities should strategically develop and implement activities uniquely connecting and supporting their home communities, states, and regions.
Read MoreNew article on MNEs, digital platforms, business ecosystems, and AI
in Leadership, Strategy
In a July 2026 article in Management International Review, “Orchestration Theory of the Multinational Enterprise in Digital Platform and AI Ecosystems," Professor David J. Teece and Professor Christos N. Pitelis advance orchestration theory as a framework for understanding firm organization and strategy in the current era.
Read MoreNew Podcast Episode: Do Patents Help or Hurt Drug Access?
Dr. Bowman Heiden joins Josh and Ashley Sloat of Aurora Patents, to discuss current issues in pharmaceutical innovation and access to medicine, in a July 8, 2026 podcast.
Read MoreConstitution of Innovation Panel at 3rd DCI Conference
As part of the Third Dynamic Competition Initiative (DCI) Conference, a panel discussion with Bowman Heiden, Lorenzo Allio, Miguel Poiares Maduro, and Branislav Turcina examined the relationship between European regulation and innovation, the Draghi report, and the Constitution of Innovation (CoI).
Read MoreEira Conference October 2026: Competing for the Cure: Intellectual Property, Innovation Policy, and Biopharmaceutical Ecosystems
We are pleased to announce the upcoming conference hosted by the Eira Initiative in association with the Berkeley Policy Institute: Competing for the Cure: Intellectual Property, Innovation Policy, and Biopharmaceutical Ecosystems (October 29–30, 2026).
Read MoreAmicus Brief to D.C. Circuit Court in United States v. Google
A notable group of thought leaders addressing innovation law and economics, including Berkeley Policy Institute (BPI) executive director David J. Teece, have submitted an amicus brief to the U.S. Court of Appeals for the D.C. Circuit regarding United States v. Google LLC.
Read MoreDynamic Universities: Strategic Leadership for Higher Education’s Turbulent Future
in Management, Leadership
In a May 2026 post in CMR Insights, Professor David Teece and Professor Sohvi Heaton offer key guidance for university executives and boards to manage their institutions through challenging times in the sector.
Read MoreWhat do the numbers reveal on whether merger policy is ‘too permissive’ or ‘too strict’?
Company mergers, and the regulations surrounding them, occupy a central policy debate among lawmakers, scholars, and the general public in many countries. A core question emerges from this pressing topic: How to best interpret the data about merger prohibition rates and merger deterrence?
Read MoreEvergreening's Empirical Chasm: A Working Paper from the Eira Initiative
A working paper from the Eira Initiative examines data on pharmaceutical innovation. The author, Professor Erika Lietzan, finds that the evergreening narrative (which alleges companies patent revisions to drugs to prolong intellectual property protection) is conceptually flawed, misrepresents how patents and exclusivity intersect with drug approval frameworks, and risks misleading policymakers into enacting measures that would punish innovation to the detriment of patients.
Read MoreAntitrust Analysis from Professor Jonathan Barnett on Recent Cases
Writing in Truth on the Market, Professor Jonathan Barnett investigates several recent merger cases, and how regulator decisions might have harmed economic value, consumers, and employees.
Read MoreProfessor Chris Pitelis Interview on Orchestration, Value Creation, and the Public Good
in Management, Strategy
Professor Chris Pitelis has a new interview video available on his research and scholarship, in which he relates multiple topics across economics and management areas, including dynamic capabilities and a 2018 paper co-authored with David Teece.
Read MoreProfessor Mary-Anne Williams Post on Agentic AI and Dynamic Capabilities
in Strategy, Management
Professor Mary-Anne Williams has written a detailed post with an accompanying presentation slide deck on LinkedIn, addressing the interrelated topics of agentic AI, human-AI collaboration, and novel approaches for adaptable orchestration strategies.
Read More3rd DCI Conference Videos Available on YouTube
in DCI
Multiple videos from the Third Annual Dynamic Competition Initiative (DCI) Conference, held in April 2026, are now available to watch on YouTube.
Read MorePenrose Lectures at SOAS University of London: April 28 & 29, 2026
in Strategy
Is Edith Penrose today more relevant than ever?
Professor Chris Pitelis will deliver this year’s Penrose Public Lectures at SOAS University of London.
📅 Tuesday 28 & Wednesday 29 April, 2026
How the American Research University Survives
Writing in Issues in Science and Technology, Robert Brown and Bruce Guile explore the current state of American higher education and research enterprise sectors.
Read MoreAI + Intellectual Capital + IP: New Challenges and Opportunities for Companies
in Strategy
Writing as a guest for The Intangible Investor column in IPWatchdog, David Teece examines the growing use of artificial intelligence, and its implications for the intellectual capital and intellectual property rights of firms.
Read More